159 related articles for article (PubMed ID: 8213583)
1. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.
Am J Cardiol; 1993 Nov; 72(14):1031-7. PubMed ID: 8213583
[TBL] [Abstract][Full Text] [Related]
2. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
[TBL] [Abstract][Full Text] [Related]
3. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
[TBL] [Abstract][Full Text] [Related]
4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
Shepherd J; Cobbe SM; Ford I; Isles CG; Lorimer AR; MacFarlane PW; McKillop JH; Packard CJ
N Engl J Med; 1995 Nov; 333(20):1301-7. PubMed ID: 7566020
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
N Engl J Med; 1998 Nov; 339(19):1349-57. PubMed ID: 9841303
[TBL] [Abstract][Full Text] [Related]
7. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
Lewis SJ; Moye LA; Sacks FM; Johnstone DE; Timmis G; Mitchell J; Limacher M; Kell S; Glasser SP; Grant J; Davis BR; Pfeffer MA; Braunwald E
Ann Intern Med; 1998 Nov; 129(9):681-9. PubMed ID: 9841599
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group.
Am J Cardiol; 1993 Jun; 71(16):1408-14. PubMed ID: 8517385
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.
Saito Y; Shirai K; Sasaki N; Shinomiya M; Yoshida S;
J Atheroscler Thromb; 2002; 9(2):99-108. PubMed ID: 12236319
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.
Chan P; Tomlinson B; Lee CB; Pan WH; Lee YS
Hypertension; 1996 Oct; 28(4):647-51. PubMed ID: 8843892
[TBL] [Abstract][Full Text] [Related]
16. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
Pfeffer MA; Sacks FM; Moyé LA; East C; Goldman S; Nash DT; Rouleau JR; Rouleau JL; Sussex BA; Theroux P; Vanden Belt RJ; Braunwald E
J Am Coll Cardiol; 1999 Jan; 33(1):125-30. PubMed ID: 9935018
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
Morris R; Robinson G; Tilyard M; Gurr E
N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
[TBL] [Abstract][Full Text] [Related]
18. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
[TBL] [Abstract][Full Text] [Related]
20. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]